Immunosuppression: Coronavirus

(asked on 19th April 2022) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what estimate he has made of the total number of people in the UK who (a) are immunocompromised or immunosuppressed and (b) were formerly identified as clinically extremely vulnerable in the latest period for which figures are available.


Answered by
Maggie Throup Portrait
Maggie Throup
This question was answered on 27th April 2022

Those whose immune systems mean they continue to be at high risk of severe illness from COVID-19 may be eligible for therapies in the community, including antivirals and monoclonal antibodies, which can reduce the risk of becoming hospitalised. In England, more than 1.3 million people are eligible for monoclonal antibody treatment and antivirals.

The national shielding support programme closed at the end of September 2021. Data held by NHS Digital showed that 3,694,273 individuals were registered for care in England and previously considered as clinically extremely vulnerable or at ‘high risk’ of complications from COVID-19.

The information requested elsewhere in the United Kingdom is not held, as it is a devolved matter.

Reticulating Splines